These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34816768)

  • 1. The association between
    Phung TH; Cong Duong KN; Junio Gloria MA; Nguyen TK
    Pharmacogenomics; 2022 Jan; 23(1):49-59. PubMed ID: 34816768
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.
    Chang CC; Ng CC; Too CL; Choon SE; Lee CK; Chung WH; Hussein SH; Lim KS; Murad S
    Pharmacogenomics J; 2017 Mar; 17(2):170-173. PubMed ID: 26927288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children.
    Manuyakorn W; Likkasittipan P; Wattanapokayakit S; Suvichapanich S; Inunchot W; Wichukchinda N; Khongkhatithuml C; Thampratankul L; Kamchaisatian W; Benjaponpitak S; Mahasirimongkol S
    Epilepsy Res; 2020 May; 162():106321. PubMed ID: 32272329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the association of Lamotrigine and Phenytoin-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis with HLA-B*1502 in Iranian population.
    Sabourirad S; Mortezaee R; Mojarad M; Eslahi A; Shahrokhi Y; Kiafar B; Jarahi L; Afkhami Ardakani S; Farrokhi S
    Exp Dermatol; 2021 Feb; 30(2):284-287. PubMed ID: 33217035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B*1502 increases the risk of phenytoin or lamotrigine induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: evidence from a meta-analysis of nine case-control studies.
    Li X; Yu K; Mei S; Huo J; Wang J; Zhu Y; Zhao Z
    Drug Res (Stuttg); 2015 Feb; 65(2):107-11. PubMed ID: 24871931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.
    Wu X; Liu W; Zhou W
    J Clin Pharm Ther; 2018 Jun; 43(3):408-413. PubMed ID: 29274302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population.
    Devi K
    Int J Dermatol; 2018 Jan; 57(1):70-73. PubMed ID: 29076187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B∗ 1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population.
    Aggarwal R; Sharma M; Modi M; Garg VK; Salaria M
    Hum Immunol; 2014 Nov; 75(11):1120-2. PubMed ID: 25305458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and clinical risk factors associated with phenytoin-induced cutaneous adverse drug reactions in Thai population.
    Sukasem C; Sririttha S; Tempark T; Klaewsongkram J; Rerkpattanapipat T; Puangpetch A; Boongird A; Chulavatnatol S
    Pharmacoepidemiol Drug Saf; 2020 May; 29(5):565-574. PubMed ID: 32134161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children.
    Manuyakorn W; Siripool K; Kamchaisatian W; Pakakasama S; Visudtibhan A; Vilaiyuk S; Rujirawat T; Benjaponpitak S
    Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin-induced Stevens-Johnson syndrome with negative HLA-B*1502 allele in mainland China: two cases.
    Hu FY; Wu XT; An DM; Yan B; Stefan H; Zhou D
    Seizure; 2011 Jun; 20(5):431-2. PubMed ID: 21334226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B*1502 genotyping in two Chinese patients with phenytoin-induced Stevens-Johnson syndrome.
    Min FL; Shi YW; Liu XR; Liao WP
    Epilepsy Behav; 2011 Feb; 20(2):390-1. PubMed ID: 21216202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
    Chung WH; Chang WC; Lee YS; Wu YY; Yang CH; Ho HC; Chen MJ; Lin JY; Hui RC; Ho JC; Wu WM; Chen TJ; Wu T; Wu YR; Hsih MS; Tu PH; Chang CN; Hsu CN; Wu TL; Choon SE; Hsu CK; Chen DY; Liu CS; Lin CY; Kaniwa N; Saito Y; Takahashi Y; Nakamura R; Azukizawa H; Shi Y; Wang TH; Chuang SS; Tsai SF; Chang CJ; Chang YS; Hung SI; ;
    JAMA; 2014 Aug; 312(5):525-34. PubMed ID: 25096692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions.
    Yampayon K; Sukasem C; Limwongse C; Chinvarun Y; Tempark T; Rerkpattanapipat T; Kijsanayotin P
    Eur J Clin Pharmacol; 2017 Jul; 73(7):855-865. PubMed ID: 28391407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Tham KM; Yek JJL; Liu CWY
    Pharmacogenet Genomics; 2024 Jul; 34(5):154-165. PubMed ID: 38527170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.
    Nguyen DV; Vidal C; Chi HC; Do NTQ; Fulton R; Li J; Fernando SL
    HLA; 2017 Dec; 90(6):335-342. PubMed ID: 28884973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions.
    Shi YW; Min FL; Zhou D; Qin B; Wang J; Hu FY; Cheung YK; Zhou JH; Hu XS; Zhou JQ; Zhou LM; Zheng ZZ; Pan J; He N; Liu ZS; Hou YQ; Lim KS; Ou YM; Hui-Ping Khor A; Ng CC; Mao BJ; Liu XR; Li BM; Kuan YY; Yi YH; He XL; Deng XY; Su T; Kwan P; Liao WP
    Neurology; 2017 Jun; 88(23):2183-2191. PubMed ID: 28476759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
    Locharernkul C; Loplumlert J; Limotai C; Korkij W; Desudchit T; Tongkobpetch S; Kangwanshiratada O; Hirankarn N; Suphapeetiporn K; Shotelersuk V
    Epilepsia; 2008 Dec; 49(12):2087-91. PubMed ID: 18637831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.
    Chong KW; Chan DW; Cheung YB; Ching LK; Hie SL; Thomas T; Ling S; Tan EC
    Arch Dis Child; 2014 Jun; 99(6):581-4. PubMed ID: 24225276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.